Carisma Therapeutics Inc. Stock
Our community identified positive and negative aspects for Carisma Therapeutics Inc. stock for the coming years. 1 users see the criterium "EBIT growth" as a plus for the Carisma Therapeutics Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Carisma Therapeutics Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
B****
Cons
?
G***** c******* t* c**********
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Carisma Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Carisma Therapeutics Inc. | - | - | - | - | - | - | - |
| Heron Therapeutics Inc. | -0.220% | -3.745% | -32.094% | -64.610% | -37.702% | -50.322% | -95.078% |
| Evolus Inc | -6.990% | -4.945% | -5.978% | -68.829% | -36.514% | -55.065% | -67.664% |
| Sangamo Therapeutics Inc. | 18.000% | -12.659% | -29.343% | -56.626% | -25.243% | -83.840% | -97.492% |